Literature DB >> 27107622

Epidemiology of Clostridium difficile infections in Australia: enhanced surveillance to evaluate time trends and severity of illness in Victoria, 2010-2014.

L J Worth1, T Spelman2, A L Bull2, J A Brett2, M J Richards3.   

Abstract

BACKGROUND: With epidemic strains of Clostridium difficile posing a substantial healthcare burden internationally, there is a need for longitudinal evaluation of Clostridium difficile infection (CDI) events in Australia. AIM: To evaluate time trends and severity of illness for CDI events in Australian healthcare facilities.
METHODS: All CDI events in patients admitted to Victorian public hospitals between 1(st) October 2010 and 31(st) December 2014 were reported to the Victorian Healthcare Associated Infection Surveillance System. CDI was defined as the isolation of a toxin-producing C. difficile organism in a diarrhoeal specimen, and classified as community-associated (CA-CDI) or healthcare-associated (HA-CDI). Severe disease was defined as admission to an intensive care unit, requirement for surgery and/or death due to infection. Time trends were examined using a mixed-effects Poisson regression model, and the Walter and Edward test of seasonality was applied to evaluate potential cyclical patterns.
FINDINGS: In total, 6736 CDI events were reported across 89 healthcare facilities. Of these, 4826 (71.6%) were HA-CDI, corresponding to a rate of 2.49/10,000 occupied bed days (OBDs). The incidence of HA-CDI was highest in the fifth quarter of surveillance (3.6/10,000 OBDs), followed by a reduction. Severe disease was reported in 1.66% of events, with the proportion being significantly higher for CA-CDI compared with HA-CDI (2.21 vs 1.45%, P = 0.03). The highest and lowest incidence of HA-CDI occurred in March and October, respectively.
CONCLUSIONS: A low incidence of HA-CDI was reported in Victoria compared with US/European surveillance reports. Seasonality was evident, together with diminishing HA-CDI rates in 2012-2014. Severe infections were more common in CA-CDI, supporting future enhanced surveillance in community settings.
Copyright © 2016 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Clostridium difficile; Epidemiology; Severe disease; Surveillance; Time trends

Mesh:

Year:  2016        PMID: 27107622     DOI: 10.1016/j.jhin.2016.03.014

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  7 in total

1.  Risks factors and outcomes of Clostridium difficile infection in patients with cancer: a matched case-control study.

Authors:  Andrew I T Hebbard; Monica A Slavin; Caroline Reed; Jason A Trubiano; Benjamin W Teh; Gabrielle M Haeusler; Karin A Thursky; Leon J Worth
Journal:  Support Care Cancer       Date:  2017-02-02       Impact factor: 3.603

Review 2.  Sex and Gender Differences in Bacterial Infections.

Authors:  Sara P Dias; Matthijs C Brouwer; Diederik van de Beek
Journal:  Infect Immun       Date:  2022-09-19       Impact factor: 3.609

3.  Multi-country surveillance of Clostridioides difficile demonstrates high prevalence of spores in non-healthcare environmental settings.

Authors:  Jinhee Jo; Anne J Gonzales-Luna; Chris K Lancaster; Jacob K McPherson; Khurshida Begum; M Jahangir Alam; Kevin W Garey
Journal:  Anaerobe       Date:  2022-02-25       Impact factor: 2.837

4.  Healthcare-associated infections and antimicrobial resistance in Canadian acute care hospitals, 2014-2018.

Authors:  Canadian Nosocomial Infection Surveillance
Journal:  Can Commun Dis Rep       Date:  2020-05-07

5.  Comparative genomic and transmission analysis of Clostridioides difficile between environmental, animal, and clinical sources in China.

Authors:  Yanzi Zhou; Wangxiao Zhou; Tingting Xiao; Yunbo Chen; Tao Lv; Yuan Wang; Shuntian Zhang; Hongliu Cai; Xiaohui Chi; Xiaoyang Kong; Kai Zhou; Ping Shen; Tongling Shan; Yonghong Xiao
Journal:  Emerg Microbes Infect       Date:  2021-12       Impact factor: 7.163

6.  Diagnosis of Clostridium difficile infection by toxigenic culture and PCR assay.

Authors:  Elnaze Zare Mirzaei; Mahdi Rajabnia; Farzin Sadeghi; Elaheh Ferdosi-Shahandashti; Mahmoud Sadeghi-Haddad-Zavareh; Soraya Khafri; Abolfazl Davoodabadi
Journal:  Iran J Microbiol       Date:  2018-10

7.  Increasing rates of Clostridium difficile infection in Mexican hospitals.

Authors:  Laura Palau Dávila; Elvira Garza-González; Patricia Rodríguez-Zulueta; Rayo Morfín-Otero; Eduardo Rodríguez-Noriega; Diana Vilar-Compte; Juan C Rodríguez-Aldama; Adrián Camacho-Ortiz
Journal:  Braz J Infect Dis       Date:  2017-06-20       Impact factor: 3.257

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.